Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Gurney, Elinor Millar, A. Dunn, R. Pirie, Michelle Mako, J. Manderson, C. Hardie, C. Jackson, R. North, Myra Ruka, N. Scott, D. Sarfati (2021)
The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 eliminationThe Lancet Regional Health: Western Pacific, 10
G. Luker, A. Boettcher (2021)
Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are NowRadiology: Imaging Cancer, 3
K. Rolston (2017)
Infections in Cancer Patients with Solid Tumors: A ReviewInfectious Diseases and Therapy, 6
(European Medicines Agency. Verzenios (abemaciclib): summary of product characteristics. 2018. https://www.ema.europa.eu/en/documents/product-information/verzenios-epar-product-information_en.pdf. Accessed September 20 2021.)
European Medicines Agency. Verzenios (abemaciclib): summary of product characteristics. 2018. https://www.ema.europa.eu/en/documents/product-information/verzenios-epar-product-information_en.pdf. Accessed September 20 2021.European Medicines Agency. Verzenios (abemaciclib): summary of product characteristics. 2018. https://www.ema.europa.eu/en/documents/product-information/verzenios-epar-product-information_en.pdf. Accessed September 20 2021., European Medicines Agency. Verzenios (abemaciclib): summary of product characteristics. 2018. https://www.ema.europa.eu/en/documents/product-information/verzenios-epar-product-information_en.pdf. Accessed September 20 2021.
Kathryn Hawrot, L. Shulman, I. Bleiweiss, E. Wilkie, Zachary Frosch, R. Jankowitz, A. Laughlin (2021)
Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 PandemicJCO Oncology Practice, 17
F. Poggio, M. Tagliamento, M. Maio, V. Martelli, A. Maria, E. Barisione, M. Grosso, F. Boccardo, P. Pronzato, L. Mastro, M. Lambertini (2020)
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities.JCO oncology practice
Jing Yu, Ouyang Wen, M. Chua, C. Xie (2020)
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 6
(Demony C. Portugal's health system on brink of collapse as COVID-19 cases surge. Reuters. 2021. https://www.reuters.com/article/us-health-coronavirus-portugal-idUSKBN29M0L3.)
Demony C. Portugal's health system on brink of collapse as COVID-19 cases surge. Reuters. 2021. https://www.reuters.com/article/us-health-coronavirus-portugal-idUSKBN29M0L3.Demony C. Portugal's health system on brink of collapse as COVID-19 cases surge. Reuters. 2021. https://www.reuters.com/article/us-health-coronavirus-portugal-idUSKBN29M0L3., Demony C. Portugal's health system on brink of collapse as COVID-19 cases surge. Reuters. 2021. https://www.reuters.com/article/us-health-coronavirus-portugal-idUSKBN29M0L3.
(World Health Organization. Listings of WHO’s response to COVID-19. 2020. https://www.who.int/news/item/29-06-2020-covidtimeline.)
World Health Organization. Listings of WHO’s response to COVID-19. 2020. https://www.who.int/news/item/29-06-2020-covidtimeline.World Health Organization. Listings of WHO’s response to COVID-19. 2020. https://www.who.int/news/item/29-06-2020-covidtimeline., World Health Organization. Listings of WHO’s response to COVID-19. 2020. https://www.who.int/news/item/29-06-2020-covidtimeline.
A. Jafari, M. Rezaei-Tavirani, S. Karami, Mohsen Yazdani, H. Zali, Z. Jafari (2020)
Cancer Care Management During the COVID-19 PandemicRisk Management and Healthcare Policy, 13
I. Poddubnaya, И. Поддубная, D. Sychev, Дмитрий Сычев, G. Abuzarova, Г. Абузарова, A. Allakhverdiev, А Аллахвердиев, P. Arkhiri, П Архири, L. Babicheva, Л Бабичева, M. Baranova, М Баранова, M. Volkova, Мілиця Волкова, A. Ignatova, А Игнатова, A. Kashurnikov, А Кашурников, R. Kniazev, Роман Князев, I. Kolyadina, И Колядина, I. Komarov, И Комаров, A. Kriukov, Александр Крюков, N. Levitskaia, Н Левицкая, V. Liadov, Владимир Лядов, O. Malikhova, О Малихова, S. Nered, С Неред, N. Orel, Надежда Орел, S. Podviaznikov, С Подвязников, I. Sagaidak, И Сагайдак, R. Sarmanaeva, Р Сарманаева, I. Stilidi, И Стилиди, O. Trofimova, О. Трофимова, G. Tumian, Г Тумян, T. Kharitonova, Тамара Харитонова (2020)
Cancer patient management during the COVID-19 pandemic Training module. Version 2 from 30.04.2020Journal of Modern Oncology, 22
Rui Nogueira (2018)
Programa Nacional para as Doenças Oncológicas: o despacho n.º 8254/2017, de 21 de setembro, do Secretário de Estado Adjunto e da Saúde, merece mais atenção e representa um primeiro passo para a orientação de soluções, 34
P. Tarantino, S. Tolaney, N. Harbeck, J. Cortés, G. Curigliano (2021)
Anthracyclines for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Are We Ready to Let Them Go?Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(2021)
Portugal's health system on brink of collapse as COVID-19 cases surge. Reuters
Zunyou Wu, J. McGoogan (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.JAMA
M. Amador, X. Matías-Guiu, G. Sancho-Pardo, J. Martínez, J. Torre-Montero, A. Saiz, P. Garrido, R. García-Sanz, Á. Rodríguez-Lescure, L. Paz-Ares (2021)
Impact of the COVID-19 pandemic on the care of cancer patients in SpainESMO Open, 6
(European Medicines Agency. Kisqali (ribociclib): summary of product characteristics. 2017. https://www.ema.europa.eu/en/documents/product-information/kisqali-epar-product-information_en.pdf. Accessed September 20 2021.)
European Medicines Agency. Kisqali (ribociclib): summary of product characteristics. 2017. https://www.ema.europa.eu/en/documents/product-information/kisqali-epar-product-information_en.pdf. Accessed September 20 2021.European Medicines Agency. Kisqali (ribociclib): summary of product characteristics. 2017. https://www.ema.europa.eu/en/documents/product-information/kisqali-epar-product-information_en.pdf. Accessed September 20 2021., European Medicines Agency. Kisqali (ribociclib): summary of product characteristics. 2017. https://www.ema.europa.eu/en/documents/product-information/kisqali-epar-product-information_en.pdf. Accessed September 20 2021.
E. Azambuja, D. Trapani, S. Loibl, S. Delaloge, E. Senkus, C. Criscitiello, P. Poortman, M. Gnant, S. Cosimo, J. Cortés, F. Cardoso, S. Paluch-Shimon, G. Curigliano (2020)
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast CancerESMO Open, 5
W. Qi, Zan Shen, F. Lin, Yuan‐jue Sun, D. Min, Lina Tang, Aina He, Yang Yao (2013)
Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trialsCurrent Medical Research and Opinion, 29
K. Saini, D. Martins-Branco, M. Tagliamento, L. Vidal, Navneet Singh, K. Punie, M. Saini, I. Chico, G. Curigliano, E. Azambuja, M. Lambertini (2021)
Emerging issues related to COVID-19 vaccination in patients with cancer.Oncology and therapy
Jii Lee, M. Jung, June-Hyuk Kim, Bo Kim, Yeol Kim, Young Kim, Byung Kim, Jin Kim, S. Moon, K. Park, Meerim Park, H. Park, S. Sim, H. Yoon, Soo Lee, Eunyoung Lee, J. Chun, Y. Chung, S. Jung, Jinsoo Chung, Eun-Sook Lee, H. Chung, T. Yun, S. Rha (2021)
Guidelines for Cancer Care during the COVID-19 Pandemic in South KoreaCancer Research and Treatment : Official Journal of Korean Cancer Association, 53
Lei Zhang, F. Zhu, L. Xie, C. Wang, Jun Wang, R. Chen, P. Jia, H. Guan, L. Peng, Yan Chen, P. Peng, P. Zhang, Q. Chu, Q. Shen, Yu Wang, S. Xu, Jianping Zhao, M. Zhou (2020)
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 31
Agnes Coutinho, K. Chapman (2011)
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insightsMolecular and Cellular Endocrinology, 335
Verzenios (abemaciclib): summary of product characteristics
W. Liang, W. Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet. Oncology, 21
A. Desai, Sonali Sachdeva, Tarang Parekh, R. Desai (2020)
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis.JCO global oncology, 6
M. Shirke, S. Shaikh, A. Harky (2020)
Implications of Telemedicine in Oncology during the COVID-19 PandemicActa Bio Medica : Atenei Parmensis, 91
(European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2020. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic.)
European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2020. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic.European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2020. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic., European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2020. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic.
S. Murthy, C. Gomersall, R. Fowler (2020)
Care for Critically Ill Patients With COVID-19.JAMA
Dawei Wang, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu, Jing Zhang, Binbin Wang, Hui Xiang, Zhenshun Cheng, Y. Xiong, Yan Zhao, Yirong Li, Xinghuan Wang, Z. Peng (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.JAMA
J. Blay, S. Boucher, B. Vu, C. Cropet, S. Chabaud, D. Pérol, E. Barranger, M. Campone, T. Conroy, C. Coutant, R. Crevoisier, A. Debreuve-Theresette, J. Delord, P. Fumoleau, J. Gentil, F. Gomez, O. Guerin, A. Jaffré, E. Lartigau, C. Lemoine, M. Mahé, F. Mahon, H. Mathieu‐Daudé, Y. Merrouche, F. Penault-Llorca, X. Pivot, J. Soria, G. Thomas, P. Vera, T. Vermeulin, P. Viens, M. Ychou, S. Beaupère (2021)
Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in FranceESMO Open, 6
F. Paes, I. Luis, R. Costa, O. Filho, M. Hughes, Katya Losk, Kristen Camuso, C. Bunnell, M. Golshan, E. Winer, N. Lin (2015)
Variation in the use of granulocyte-colony stimulating factor (G-CSF) for dose dense paclitaxel: A single institution retrospective study.Journal of Clinical Oncology, 33
C. Minichsdorfer, G. Jeryczynski, C. Krall, Alina Achhorner, Ariane Caraan, Sabina Pasalic, Katharina Reininger, C. Wagner, R. Bartsch, M. Preusser, A. Laggner, M. Raderer, T. Fuereder (2021)
Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centreEuropean Journal of Clinical Investigation, 51
M. Lambertini, A. Toss, A. Passaro, C. Criscitiello, C. Cremolini, C. Cardone, F. Loupakis, G. Viscardi, I. Meattini, M. Dieci, R. Ferrara, R. Giusti, M. Maio (2020)
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspectiveESMO Open, 5
(Direção-Geral da Saúde. Programa Nacional para as Doenças Oncológicas. 2020. https://www.dgs.pt/pns-e-programs/programs-de-health-prioritarios/doencas-oncologicas.aspx. Accessed September 20 2021.)
Direção-Geral da Saúde. Programa Nacional para as Doenças Oncológicas. 2020. https://www.dgs.pt/pns-e-programs/programs-de-health-prioritarios/doencas-oncologicas.aspx. Accessed September 20 2021.Direção-Geral da Saúde. Programa Nacional para as Doenças Oncológicas. 2020. https://www.dgs.pt/pns-e-programs/programs-de-health-prioritarios/doencas-oncologicas.aspx. Accessed September 20 2021., Direção-Geral da Saúde. Programa Nacional para as Doenças Oncológicas. 2020. https://www.dgs.pt/pns-e-programs/programs-de-health-prioritarios/doencas-oncologicas.aspx. Accessed September 20 2021.
I. Halim, M. Ashri, W. Sadda (2011)
Weekly paclitaxel versus standard 3-week schedule in patients with metastatic breast cancer.
(European Society for Medical Oncology. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast cancer. 2020.)
European Society for Medical Oncology. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast cancer. 2020.European Society for Medical Oncology. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast cancer. 2020., European Society for Medical Oncology. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast cancer. 2020.
K. Saini, M. Tagliamento, M. Lambertini, R. Mcnally, Marco Romano, Manuela Leone, G. Curigliano, E. Azambuja (2020)
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studiesEuropean Journal of Cancer, 139
A. Jazieh, S. Chan, G. Curigliano, N. Dickson, V. Eaton, J. García-Foncillas, T. Gilmore, L. Horn, D. Kerr, Jeeyun Lee, C. Mathias, A. Nogueira-Rodrigues, L. Pierce, Á. Rogado, R. Schilsky, J. Soria, J. Warner, Kazuhiro Yoshida (2020)
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsJCO Global Oncology, 6
M. Richards, Michael Anderson, Paul Carter, B. Ebert, Elias Mossialos (2020)
The impact of the COVID-19 pandemic on cancer careNature Cancer, 1
I. Halim, M. Ashri, W. Sadda (2011)
Weekly paclitaxel versus standard 3-week schedule in patients with metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
M. Thill, Marcus Schmidt (2018)
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerTherapeutic Advances in Medical Oncology, 10
A. Gongora, G. Werutsky, D. Jardim, A. Nogueira-Rodrigues, C. Barrios, C. Mathias, F. Maluf, R. Riechelmann, Maurício Fraga, Henry Gomes, W. William, C. Yamada, G. Castro, D. Rosa, A. Melo, R. Sala, E. Bustamante, D. Bretel, O. Arrieta, A. Cardona, D. Bastos (2021)
Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420)JCO Global Oncology, 7
(2020)
Listings of WHO's response to COVID-19
Elinor Millar, J. Gurney, S. Beuker, Moahuia Goza, M. Hamilton, C. Hardie, Christopher Jackson, Michelle Mako, T. Middlemiss, Myra Ruka, Nicola Willis, D. Sarfati (2021)
Maintaining cancer services during the COVID-19 pandemic: the Aotearoa New Zealand experienceThe Lancet Regional Health: Western Pacific, 11
IntroductionCancer care providers have faced many challenges in delivering safe care for patients during the COVID-19 pandemic. This cross-sectional survey-based study investigated the impact of the pandemic on clinical practices of Portuguese medical oncologists caring for patients with breast cancer.MethodsAn anonymous online survey comprising 42 questions gathered information regarding COVID-19 testing, treatment in (neo)adjuvant and metastatic settings, and other aspects of breast cancer management. Practices before and during the pandemic were compared, and potential differences in outcomes according to respondents’ regions, case volumes, and practice type were explored.ResultsOf 129 respondents, 108 worked in the public health system, giving a representative national picture of the impact of the COVID-19 pandemic on breast cancer management. Seventy-one percent of respondents reported a reduction in visits for new cases of breast cancer, and there was a shift towards increased use of telemedicine. Clinical decision-making was largely unaffected in the most aggressive indications (i.e., triple-negative, HER2-positive, visceral crisis). The use of neoadjuvant therapy increased when access to surgery was difficult, whereas dose-dense regimens decreased, and cyclin-dependent kinase 4/6 inhibitor treatment decreased for less aggressive disease and increased for more aggressive disease. The use of oral formulations and metronomic chemotherapy regimens increased, and clinical trial participation decreased. Some differences by respondents’ region and case volume were noted.ConclusionMedical oncologists in Portugal implemented many changes during the COVID-19 pandemic, most of which were logical and reasonable responses to the current healthcare emergency; however, the true impact on patient outcomes remains unknown.
Oncology and Therapy – Springer Journals
Published: Jun 1, 2022
Keywords: Breast cancer; Clinical practice; COVID-19; Patient management
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.